Investigations of calsequestrin as a target for anthracyclines: Comparison of functional effects of daunorubicin, daunorubicinol, and trifluoperazine

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1505-1512

  Charlier Jr , Henry A ^a,b   Olson, Richard D ^b,c,d   Thornock, Carissa M ^a   Mercer, Wendy K ^a   Olson, David R ^d   Broyles, T Stephen ^a   Muhlestein, Dawn J ^a   Larson, Corianton L ^a   Cusack, Barry J ^b,c,d   Shadle, Susan E ^a,b,c  

^a BOISE STATE UNIVERSITY   (United States)

^b Mt States Tum and Med Res Inst   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Boise VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CALCIUM BINDING PROTEIN; CALSEQUESTRIN; DAUNORUBICIN; DAUNORUBICINOL; TRIFLUOPERAZINE;

ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOTOXICITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING; DRUG TARGETING; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

ANIMALS; ANTHRACYCLINES; CALSEQUESTRIN; DAUNORUBICIN; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; MYOCARDIAL CONTRACTION; RABBITS; TRIFLUOPERAZINE;

EID: 20944438956     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.005728     Document Type: Article

References (47)

1. Arai M, Tomaru K, Takizawa T, Sekiguchi K, Yokowama T, Suzuki T, and Nagai R (1998) Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J Mol Cell Cardiol 30:243-254.
2. Bers DM (1985) Calcium influx and sarcoplasmic reticulum calcium release in cardiac muscle activation during postrest recovery. Am J Physiol 248:H366-H381.
3. Bose D, Hryshko LV, King BW, and Chau T (1988) Control of interval-force relation in canine ventricular myocardium studied with ryanodine. Br J Pharmacol 95:811-820.
4. Bouchard RA and Bose D (1989) Analysis of the interval-force relationship in rat and canine ventricular myocardium. Am J Physiol 257:H2036-H2047.
5. Bouchard RA, Hryshko LV, Saha JK, and Bose D (1989) Effects of caffeine and ryanodine on depression of post-rest tension development produced by Bay K 8644 in canine ventricular muscle. Br J Pharmacol 97:1279-1291.
6. Brixius K, Wollmer A, Bolck B, Mehlhorn U, and Schwinger R (2003) Ser16 but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflueg Arch Eur J Physiol 447:150-157.
7. Burke BE, Gambliel H, Olson RD, Bauer FK, and Cusack BJ (2000) Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat. Br J Pharmacol 131:1-4.
8. Burke BE, Mushlin PS, Cusack BJ, Olson SJ, Gambliel HA, and Olson RD (2002) Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity. Cardiovasc Toxicol 2:41-51.
9. Cusack BJ, Mushlin PS, Voulelis LD, Li X, Boucek RJ Jr, and Olson RD (1993a) Daunorubicin-induced cardiac injury in the rabbit: a role for daunorubicinol? Toxicol Appl Pharmacol 118:177-185.
10. Cusack BJ, Young SP, Driskell J, and Olson RD (1993b) Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit. Cancer Chemother Pharmacol 32:53-58.
11. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Zakrzewski VG, Montgomery JA, Stratmann RE, Burant JC, et al. (1998) Gaussian 98 (revision A.7), Gaussian, Inc., Pittsburgh PA.
12. Gatti G, Trifari S, Mesaeli N, Parker JMR, Michalak M, and Meldolesi J (2001) Head-to-tail oligomerization of calsequestrin: a novel mechanism for heterogeneous distribution of endoplasmic reticulum luminal proteins. J Cell Biol 154:525-534.
13. Györke I, Hester NA, Jones LR, and Györke S (2004) Role of calsequestrin, triadin and junctin in conferring cardiac ryanodine responsiveness to luminal calcium. Biophys J 86:2121-2128.
14. 2+-induced folding and aggregation of skeletal muscle sarcoplasmic reticulum calsequestrin: the involvement of the trifluoperazine-binding site. J Biol Chem 268:24635-24641.
15. 2+ release. Br J Pharmacol 118:690-694.
16. Janczewski AM and Lewartowski B (1986) The effect of prolonged rest on calcium exchange and contractions in rat and guinea-pig ventricular myocardium. J Mol Cell Cardiol 18:1233-1242.
17. Janicak PG, Javaid JI, Sharma RP, Comaty JE, Peterson J, and Davis JM (1989) Trifluoperazine plasma levels and clinical response. J Clin Psychopharmacol 8:340-346.
18. Johnson ML and Frasier SG (1985) Nonlinear least-squares analysis. Methods Enzymol 117:301-342.
19. Jones TA, Cowan S, Zou J-Y, and Kjeldgaard M (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A47:10-119.
20. Kang C (2001) Calsequestrin, in Handbook of Metalloproteins (Messerschmidt A, Cygler M, and Bode W eds) pp 692-703, Wiley, New York.
21. Kimura J (1993) Effects of various calmodulin antagonists on Na/Ca exchange current of single ventricular cells of guinea-pig. Pflueg Arch Eur J Physiol 424:523-528.
22. Knollman BC, Knollmann-Ritschel BE, Weissman NJ, Jones LR, and Morad M (2000) Remodeling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol (Lond) 525:483-498.
23. Kobayashi YM, Alseikhan BA, and Jones LR (2000) Localization and characterization of the calsequestrin-binding domain of triadin 1: evidence for a charged (3-strand in mediating the protein-protein interaction. J Biol Chem 275:17639-17646.
24. Koyama K and Himori N (1988) Simultaneous assessment of effects of calmodulin antagonists and Ca channel blockers on the electrophysiological and mechanical characteristics in excised guinea-pig papillary muscles. Arch Int Pharmacodyn 282:141-156.
25. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 183:265-275.
26. 2+ handling. Jpn Circ J 84:65-71.
27. Midha KK, Korchinski ED, Roscoe RM, Hawes EM, Cooper JK, and McKay G (1984) Relative bioavailability of a commercial trifluoperazine tablet formulation using a radioimmunoassay technique. J Pharm Sci 73:261-263.
28. 2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. J Biol Chem 263:1376-1381.
29. Mushlin PS, Cusack BJ, Boucek RJ Jr, Andrejuk T, Li X, and Olson RD (1993) Time-related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function. Br J Pharmacol 110:975-982.
30. Olson RD, Li X, Palade P, Shadle SE, Mushlin PS, Gambliel HA, Fill M, Boucek RJ Jr, and Cusack BJ (2000) Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol. Toxicol Appl Pharmacol 169:168-176.
31. Palade P and Vergra J (1982) Arsenazo III and antipyrylazo III calcium transients in single skeletal muscle fibers. J Gen Physiol 79:679-707.
32. 2+ regulation. J Biol Chem 278:16176-16182.
33. Park IY, Kim E, Park H, Fields K, Dunker KA, and Kang C (2005) Interaction between cardiac calsequestrin and drugs with known cardiotoxicity. Mol Pharmacol 67:97-104.
34. Pessah IN, Durie EL, Schiedt MJ, and Zimanyi I (1990) Anthraquinone-sensitized calcium release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy. Mol Pharmacol 37:503-514.
35. Sato Y, Schmidt AG, Kiriazis H, Hoit BD, and Kranias EG (2003) Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin. Mol Cell Biochem 242:19-25.
36. 2+ metallochromic indicator. Biochemistry 17:1378-1386.
37. Shadle SE, Bammel BP, Cusack BJ, Knighton BK, Olson SJ, Mushlin PS, and Olson RD (2000) Daunorubicin cardiotoxicity: evidence for the importance of the quinone moiety in a free-radical independent mechanism. Biochem Pharmacol 60:1435-1444.
38. Slupsky JR, Ohnishi M, Carpenter MR, and Reithmeier RAF (1987) Characterization of cardiac calsequestrin. Biochemistry 26:6539-6544.
39. Stewart DJ, Grewaal D, Green RM, Mikael N, Goel R, Montpetit VAJ, and Redmond MD (1993) Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer Res 13:1945-1952.
40. 2+ exchange determines sarcoplasmic reticulum calcium content. Am J Physiol 250:H654-H661.
41. Takanashi S and Bachur NR (1976) Adriamycin metabolism in man: evidence from urinary metabolism. Drug Metab Dispos 4:79-87.
42. Terentyev D, Viatchenko-Karpinski S, Györke I, Volpe P, Williams SC, and Györke S (2003) Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 100:11759-11764.
43. Viatchenko-Karpinski S, Terentyev D, Györke I, Terentyeva R, Volpe P, Priori SG, Napolitano C, Nori A, Williams SC, and Györke S (2004) Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 94:471-477.
44. Wang GX, Wang YX, Zhou XB, and Korth M (2001) Effects of doxorubicinol on excitation-contraction coupling in guinea pig ventricular myocytes. Eur J Pharmacol 423:99-107.
45. Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, and Kang C (1998) Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulura. Nat Struct Biol 5:476-483.
46. Wykovsky W, Hauptner R, and Suko J (1988) Drug-induced calcium release from heavy sarcoplasmic reticulum of skeletal muscle. Biochim Biophys Acta 938:89-96.
47. Zucchi R and Danesi R (2003) Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3:151-171.